Skip to main content

Pharmacokinetics of Aging

  • Chapter
  • First Online:

Abstract

Aging is a determinant in the biotransformation of drugs with respect to their therapeutic efficacy and safety. Demographics indicate an aging population with a longer life expectancy. The elderly are the most medicated segment of the population, with the average older person taking three times more drugs compared to the young. Most older adults have at least one chronic disease state. Significant aging physiological changes impact on pharmacokinetics and pharmacodynamics, contributing to a higher incidence of adverse events, worsened by polypharmacy. About 10% of all hospital admissions in the elderly relate to drug interactions. Pharmacokinetics refer to the absorption, distribution, metabolism, and excretion of drugs in the body. Pharmacodynamics relate to the pharmacological mechanism of drug action at its particular targets, including therapeutic effects and adverse effects. Pharmacotherapy is a challenge for the health care practitioner because of the need to dose appropriately to account for age-related changes in older adults.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Wauthier V, Verbeeck RK, Calderon PB. The effect of ageing on cytochrome P450 enzymes: consequences for drug biotransformation in the elderly. Curr Med Chem. 2007;14:745–57.

    Article  PubMed  CAS  Google Scholar 

  2. Modig S, Kristensson J, Ekwall AK, et al. Frail elderly patients in primary care—their medication knowledge and beliefs about prescribed medicines. Eur J Clin Pharmacol. 2009;65:151–5.

    Article  PubMed  Google Scholar 

  3. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41:67–76.

    Article  PubMed  CAS  Google Scholar 

  4. Handler SM, Hanlon JT, Perera S, et al. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc. 2008;56:805–15.

    Article  Google Scholar 

  5. DiPiro JT, Spruill WJ, Wade WE, et al. Concepts in clinical pharmacokinetics. 5th ed. Bethesda: American Society of Health-System Pharmacists; 2010.

    Google Scholar 

  6. Rivera R, Antognini J. Perioperative drug therapy in elderly patients. Anesthesiology. 2009;110:1176–81.

    Article  PubMed  Google Scholar 

  7. Howland R. Effects of aging on pharmacokinetic and pharmacodynamic drug processes. J Psychosoc Nurs Ment Health Serv. 2009;47:15–8.

    Google Scholar 

  8. Delafuente JC. Pharmacokinetic and pharmacodynamic alternation in the geriatric patient. Consult Pharm. 2008;23:324–34.

    Article  PubMed  Google Scholar 

  9. Sostress C, Gargallo C, Lanas A. Drug-related damage of the ageing gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2009;23:849–60.

    Article  Google Scholar 

  10. Rosenthal T, Nussinovitch N. Managing hypertension in the elderly in light of the changes during aging. Blood Press. 2008;17:186–94.

    Article  PubMed  Google Scholar 

  11. Delco F, Tchambaz L, Schlienger R, et al. Dose adjustment in patients with liver disease. Drug Saf. 2005;28:529–45.

    Article  PubMed  CAS  Google Scholar 

  12. Carnevale V, Pastore L, Camaioni M, et al. Estimate of renal function in oldest old inpatients by MDRD study equation, Mayo Clinic equation and creatinine clearance. J Nephrol. 2010;23(3):306–13.

    PubMed  Google Scholar 

  13. Olyaei AJ, Bennett WM. Drug dosing in the elderly patients with chronic kidney disease. Clin Geriatr Med. 2009;25(3):459–527.

    Article  PubMed  Google Scholar 

  14. Hilmer SN. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21:217–30.

    Article  PubMed  CAS  Google Scholar 

  15. Merle M, Laroche ML, Dantoine T, Charmes JP. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005;22:375–92.

    Article  PubMed  Google Scholar 

  16. Couteur DG. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet. 1998;34:359–73.

    Article  PubMed  Google Scholar 

  17. Edholm M. Regulatory aspects of pharmacokinetic profiling in special populations: a European perspective. Clin Pharmacokinet. 2008;47:693–701.

    Article  PubMed  Google Scholar 

  18. Ali T, Roberts DN, Tiernay WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122:896–903.

    Article  PubMed  CAS  Google Scholar 

  19. Fock KM, Ang TL, Bee LC, Lee EJ. Proton pump inhibitors: Do differences in pharmacokinetics translate into differences in clinical outcomes? Clinical Pharmacokinet. 2008;47:1–6.

    Google Scholar 

  20. Qasim A, O’Morain CA, O’Connor HJ. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration. Fundam Clin Pharmacol. 2009;23:43–52.

    Article  PubMed  CAS  Google Scholar 

  21. Kamiya T, Adachi H, Hirako M, et al. Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease. J Gastroenterol. 2009;44:183–9.

    Article  PubMed  CAS  Google Scholar 

  22. Arai K, Takeuchi Y, Watanabe H, et al. Prokinetics influence the pharmacokinetics of rabeprazole. Digestion. 2008;78:67–71.

    Article  PubMed  CAS  Google Scholar 

  23. Pel-Little RE, Schuurmans MJ, Emmelot-Vonk MH, et al. Frailty: defining and measuring of a concept. J Nutr Health Aging. 2009;13(4):390–4.

    Article  Google Scholar 

  24. Patat A, Parks V, Raje S, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects. Br J Clin Pharmacol. 2009;67:299–308.

    Article  PubMed  CAS  Google Scholar 

  25. Wynne HA, Blagburn J. Drug treatment in an ageing population: practical implications. Maturitas. 2010;66(3):246–50.

    Article  PubMed  Google Scholar 

  26. Scholl S, Dellon E, Shaheen N. Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions. Am J Gastroenterol. 2011;106:386–92.

    Article  PubMed  Google Scholar 

  27. Fass R, Johnson D, Orr W, et al. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. Am J Gastroenterol. 2011;106:421–31.

    Article  PubMed  CAS  Google Scholar 

  28. Cho S, Lau S, Tandon V, et al. Geriatric drug evaluation: where are we now and where should we be in the future? Arch Intern Med. 2011;171(10):937–40.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The author would like to thank mentors Bhargava Kandala MS, PhD candidate, and Mark Haumschild PharmD, MS, both faculty at the University of Florida College of Pharmacy for providing oversight on the content and clinical relevance of this chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryan J. Haumschild MBA, BS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Haumschild, R.J. (2012). Pharmacokinetics of Aging. In: Pitchumoni, C., Dharmarajan, T. (eds) Geriatric Gastroenterology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1623-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1623-5_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1622-8

  • Online ISBN: 978-1-4419-1623-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics